1. Home
  2. WEAV vs LAB Comparison

WEAV vs LAB Comparison

Compare WEAV & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weave Communications Inc.

WEAV

Weave Communications Inc.

HOLD

Current Price

$4.88

Market Cap

487.7M

Sector

Technology

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.93

Market Cap

488.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEAV
LAB
Founded
2011
1999
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
487.7M
488.4M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
WEAV
LAB
Price
$4.88
$0.93
Analyst Decision
Strong Buy
Hold
Analyst Count
5
1
Target Price
$11.00
$1.35
AVG Volume (30 Days)
1.9M
2.4M
Earning Date
05-20-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
7.50
44.68
EPS
N/A
N/A
Revenue
$239,024,000.00
$101,937,000.00
Revenue This Year
$17.20
N/A
Revenue Next Year
$13.74
$2.63
P/E Ratio
N/A
N/A
Revenue Growth
16.99
N/A
52 Week Low
$4.72
$0.92
52 Week High
$12.19
$1.72

Technical Indicators

Market Signals
Indicator
WEAV
LAB
Relative Strength Index (RSI) 33.99 23.76
Support Level N/A N/A
Resistance Level $7.31 $1.41
Average True Range (ATR) 0.29 0.07
MACD -0.00 -0.01
Stochastic Oscillator 15.71 3.02

Price Performance

Historical Comparison
WEAV
LAB

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Share on Social Networks: